If not, please take a few moments to fill out the form below. It’s free, and ensures that you receive regular alerts to the latest clinical news and other content.

Email*

Password*

Keep me logged in Forgot your password?

Email*

Solifenacin Succinate (VESIcare) for the Treatment of Overactive Bladder in Parkinson's Disease (URGE-PD)

March 24, 2011

More Overactive Bladder Clinical Trials

Painless Laser Therapy for Overactive Bladder (PLTOAB)
A Study to Investigate How Effective and Safe Solifenacin Liquid Suspension is in Treating Children/Adolescents Aged 5 to Less Than 18 Years With Symptoms of Overactive Bladder (OAB) Compared to a Non-active Drug (LION)
Study of Overactive Bladder in Women With Prolapse (SOAP)
Efficacy of Sanctura XR (Trospium Chloride) for Reducing Overactive Bladder Symptoms in Female Subjects Refractory to Detrol LA (Tolterodine Tartrate Extended Release) Daily
Single Dose Study to Measure Blood Levels and Safety of a Drug for Children With Overactive Bladder

More in Overactive Bladder Clinical Trials:

Comparison of Caffeine Reduction and Anticholinergic Medications for Treatment of Overactive Bladder

RENAL & UROLOGY NEWS SITEMAP

Nephrology

Acute Renal Failure
Anemia
Chronic Kidney Disease
Contrast Nephropathy
Cardiovascular Disease
Diabetes
Diabetic Nephropathy
Focal Segmental Glomerulosclerosis
Hemodialysis
Hypertension
Kidney Cancer
Kidney Stones
Lupus Nephritis
Peritoneal Dialysis
Secondary Hyperparathyroidism
Transplantation

Jobs

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization.

Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions

Solifenacin Succinate (VESIcare) for the Treatment of Overactive Bladder in Parkinson's Disease (URGE-PD)

More Overactive Bladder Clinical Trials

RENAL & UROLOGY NEWS SITEMAP

News

Departments

More

Nephrology

Jobs

Urology

Archives

Other Haymarket Medical Websites

International